Bufotalin-loaded biomimetic Prussian blue nanoparticles for colorectal cancer chemo-photothermal ferroptosis therapy

Nanomedicine (Lond). 2024 Jan;19(2):109-125. doi: 10.2217/nnm-2023-0293. Epub 2024 Jan 10.

Abstract

Purpose: We constructed biomimetic nanoparticles with biocompatible, tumor-targeting, laser-responsive properties for ferroptosis-induced colorectal cancer chemo-photothermal therapy, with the aim to realize double-hit ferroptosis treatment for colorectal cancer. Methods: The nanoparticles were prepared by first loading the chemotherapy drug bufotalin (CS-5) with Prussian blue (PB), then combining a hybridized erythrocyte-tumor membrane (M) with PB@CS-5 to produce PB@CS-5@M. The chemo-photothermal therapy efficiency of PB@CS-5@M was tested by in vitro and in vivo experiments. Results and conclusion: The combined PB and CS-5 act as promising ferroptosis inducers to enhance ferroptosis efficacy. The hyperthermia induced by laser stimulation can trigger PB to release CS-5 and iron and ferrous ions, which further promotes ferroptosis.

Keywords: Prussian blue; bufotalin; chemo-photothermal therapy; colorectal cancer; ferroptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomimetics
  • Bufanolides*
  • Cell Line, Tumor
  • Colorectal Neoplasms* / drug therapy
  • Doxorubicin / pharmacology
  • Ferrocyanides*
  • Ferroptosis*
  • Humans
  • Hyperthermia, Induced* / methods
  • Nanoparticles* / therapeutic use
  • Phototherapy / methods
  • Photothermal Therapy

Substances

  • ferric ferrocyanide
  • bufotalin
  • Doxorubicin
  • Bufanolides
  • Ferrocyanides